BlackRock Inc. lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 54,948,916 shares of the pharmacy operator’s stock after selling 188,472 shares during the quarter. BlackRock Inc. owned 5.13% of Walgreens Boots Alliance worth $4,303,048,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of WBA. Hudock Capital Group LLC raised its position in Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 6 shares during the period. Reilly Financial Advisors LLC raised its position in Walgreens Boots Alliance by 7.9% in the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after acquiring an additional 100 shares during the period. Orrstown Financial Services Inc. raised its position in Walgreens Boots Alliance by 14.1% in the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after acquiring an additional 213 shares during the period. Private Vista LLC raised its position in Walgreens Boots Alliance by 6,403.7% in the second quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock worth $140,000 after acquiring an additional 574,218 shares during the period. Finally, Hanson McClain Inc. raised its position in Walgreens Boots Alliance by 4.6% in the second quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock worth $156,000 after acquiring an additional 87 shares during the period. Institutional investors own 63.58% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “BlackRock Inc. Reduces Position in Walgreens Boots Alliance, Inc. (WBA)” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/11/13/blackrock-inc-reduces-position-in-walgreens-boots-alliance-inc-wba.html.

Several brokerages have recently commented on WBA. Needham & Company LLC set a $94.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Monday, July 17th. Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Thursday, October 26th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday. Royal Bank Of Canada began coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price objective on the stock. Finally, Robert W. Baird restated an “outperform” rating and set a $80.00 price objective (down from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have issued a buy rating to the stock. Walgreens Boots Alliance currently has a consensus rating of “Buy” and an average price target of $87.63.

In other news, Director John Anthony Lederer acquired 20,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, October 26th. The stock was purchased at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the purchase, the director now directly owns 50,000 shares in the company, valued at approximately $3,350,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Insiders own 13.50% of the company’s stock.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at $70.99 on Monday. Walgreens Boots Alliance, Inc. has a twelve month low of $63.82 and a twelve month high of $88.00. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59. The company has a market cap of $71,667.88, a PE ratio of 13.92, a PEG ratio of 1.26 and a beta of 1.20.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping the consensus estimate of $1.21 by $0.10. The firm had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. Walgreens Boots Alliance’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.07 EPS. sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 annualized dividend and a dividend yield of 2.25%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 42.33%.

Walgreens Boots Alliance announced that its board has authorized a stock repurchase program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to buy shares of its stock through open market purchases. Shares buyback programs are often an indication that the company’s management believes its shares are undervalued.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.